Back to Browse Journals » Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy » Volume 1

Adipose inflammation: cause or consequence of obesity-related insulin resistance

Authors Ping Jiao, Haiyan Xu

Published 23 October 2008 Volume 2008:1 Pages 25—31


Review by Single-blind

Peer reviewer comments 3

Ping Jiao, Haiyan Xu

Hallett Center for Diabetes and Endocrinology, Brown Medical School, Providence, RI, USA

Abstract: Obesity constitutes a critical risk factor for the development of many life threatening diseases, particularly insulin resistance and type 2 diabetes. Adipose tissue plays an important role in regulating whole body energy homeostatsis and obesity-related insulin resistance. Inflammation has been commonly linked to insulin resistance. Recent studies demonstrated that adipose tissue is an important source for producing inflammatory molecules in the obese state, primarily due to accumulation of macrophages. Animal models deficient in key inflammatory molecules or with reduced adipose macrophage infiltration are protected from development of obesity-related insulin resistance. Repression of adipose inflammation may be a useful approach to ameliorate obesity-associated metabolic disorders.

Keywords: adipose inflammation, insulin resistance, obesity

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at:

Readers of this article also read:

New strategy for monitoring targeted therapy: molecular imaging

Teng FF, Meng X, Sun XD, Yu JM

International Journal of Nanomedicine 2013, 8:3703-3713

Published Date: 30 September 2013

Development of biodegradable methylprednisolone microparticles for treatment of articular pathology using a spray-drying technique

Tobar-Grande B, Godoy R, Bustos P, von Plessing C, Fattal E, Tsapis N, Olave C, Gómez-Gaete C

International Journal of Nanomedicine 2013, 8:2065-2076

Published Date: 27 May 2013

Conjugation of quantum dots on carbon nanotubes for medical diagnosis and treatment

Madani SY, Shabani F, Dwek MV, Seifalian AM

International Journal of Nanomedicine 2013, 8:941-950

Published Date: 3 March 2013

Deposit buildup on prosthetic eye material (in vitro) and its effect on surface wettability

Pine KR, Sloan B, Han KYI, Swift S, Jacobs RJ

Clinical Ophthalmology 2013, 7:313-319

Published Date: 13 February 2013

Do calcifying nanoparticles really contain 16S rDNA?

Shiekh FA

International Journal of Nanomedicine 2012, 7:5051-5052

Published Date: 18 September 2012

Treating ocular surface disease: new agents in development

Fahmy AM, Hardten DR

Clinical Ophthalmology 2011, 5:465-472

Published Date: 14 April 2011

Pharmaco-management of inhalation injuries for burn survivors

Anthony C Bartley, Dale W Edgar, Fiona M Wood

Drug Design, Development and Therapy 2008, 2:9-16

Published Date: 8 January 2008

A gero-informatics tool to enhance the care of hospitalized older adults with cognitive impairment

Malaz Boustani, Stephanie Munger, Robin Beck, Noll Campbell, Michael Weiner

Clinical Interventions in Aging 2007, 2:247-253

Published Date: 15 July 2007